M
Marko Duvnjak
Researcher at University of Zagreb
Publications - 84
Citations - 1677
Marko Duvnjak is an academic researcher from University of Zagreb. The author has contributed to research in topics: Nonalcoholic fatty liver disease & Cirrhosis. The author has an hindex of 18, co-authored 84 publications receiving 1551 citations.
Papers
More filters
Journal ArticleDOI
Pathogenesis and management issues for non-alcoholic fatty liver disease
TL;DR: Although liver biopsy is currently the only way to confirm the NAFLD diagnosis and distinguish between fatty liver alone and NASH, no guidelines or firm recommendations can still be made as for when and in whom it is necessary.
Journal ArticleDOI
Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease
TL;DR: The role of adipocytokines and proinflammatory cytokines in the pathogenesis of NAFLD is explored, particularly on adiponectin, leptin and ghrelin, with a brief mention of resistin, visfatin and retinol-binding protein 4 among adipokines, and tumor necrosis factor-α, interleukin (IL)-6, IL-1, and briefly IL-18 among pro inflammatory cytokines.
Journal Article
The metabolic syndrome - an ongoing story.
Lea Duvnjak,Marko Duvnjak +1 more
TL;DR: Whatever the uncertainties of definition and etiology, metabolic syndrome represents a useful and simple clinical concept which allows earlier detection of type 2 diabetes and cardiovascular disease.
Journal ArticleDOI
The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides
Predrag Sikiric,Sven Seiwerth,Zeljko Grabarevic,Marijan Petek,Rudolf Rucman,Branko Turkovic,Ivo Rotkvić,Vjekoslav Jagić,Marko Duvnjak,Stjepan Mise,Sanja Djacic,Jadranka Separovic,Marija Veljača,Ahmet Sallmani,Marko Banić,Tomislav Brkić +15 more
TL;DR: The protection of stomach and duodenum in conjecture with anti-inflammatory effect was demonstrated for a novel 15 amino acid peptide, coded BPC 157, a fragment of the recently discovered gastric juice peptide BPC, based on Monastral blue studies.
Journal ArticleDOI
A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC
Predrag Sikiric,Marijan Petek,Rudolf Rucman,Sven Seiwerth,Zeljko Grabarevic,Ivo Rotkvić,Branko Turkovic,Vjekoslav Jagić,Boris Mildner,Marko Duvnjak,Nada Lang,Z. Danilović,A. Cviko,M. Kolega,Ahmet Sallmani,S. Djačić,Miljenko Bura,Tomislav Brkić,Marko Banić,Milan Dodig,V. Corić,Velimir N. Šimičević,Marija Veljača,Damir Erceg,Damir Ježek,L.J. Simunić-Banek,N. Skroza,Krešimir Bulić,Gojko Buljat,Miroslav Hanževački,V. Orihovac,Dražen Lučinger,Josip Čulig,Jadranka Separovic,Anton Marovic,Stjepan Mise,Ernest Suchanek,Wendy Matoz,Darko Perović,Miroslav Gjurašin,S. Mikulandra,K. Derniković,V. Cuk,I. Karakas +43 more
TL;DR: BPC, as a possible endogenous free radical scavenger and organoprotection mediator, could be a useful prototype of a new class of drugs, organoprotsective agents.